Discovery & Development

How a collaboration between different organizations aims to advance perfusion for cell and gene therapies.

Researchers demonstrate anticounterfeiting method that uses DNA oligos integrated into pharmaceutical products.

Milton Boyer and Dave Stevens delve into the company’s evolution and expertise in sterile manufacturing and drug delivery systems.

How immunotherapy could redefine cancer treatment.

Regeneron’s Gary Herman discusses the future of genetic medicines and the role of new delivery systems.

From overcoming herd mentality in research to expanding cell therapy applications in cancer treatment, we explore the future of pharma.

From regulatory hurdles to patient recruitment challenges; how can pharma improve its clinical trials?

How to mitigate the risks involved in highly potent APIs.

Regular injections to the eye are a reality for many patients. We must come up with better solutions for retinal degenerative diseases.